All Articles

Rain's new integrated loyalty platform aims to make stablecoin cards mainstream, offering partners a way to drive engagement and a proven 25% spending lift.

With a new sales head from Citi, OTC Markets is betting on deep industry ties to accelerate its expansion into new platforms and 24-hour trading.

Lexeo Therapeutics finalizes a pivotal trial for its Friedreich ataxia gene therapy, leveraging a novel trial design and accelerated FDA pathway.

A partnership born from a military hackathon shows how rapid prototyping is shattering old procurement models and accelerating autonomous defense solutions.

Tiziana Life Sciences’ chairman just increased his massive stake. We analyze if this is a vote of confidence in its novel MS drug or a risky bet on a fragile biotech.

Dominari Securities' successful $200M fund for the SpaceX IPO isn't just a trade; it's a masterclass in the new mechanics of power and profit on Wall Street.

As BOXABL eyes a UK entry amid a housing crisis, is its modular tech a real solution or a strategic move to boost its upcoming public listing?

Padel is exploding across North America, but its growth depends on quality infrastructure. A new partnership marries local manufacturing with global tech.

Nuvei's acquisition of Payoneer creates a fintech giant, combining payment acceptance and cross-border payouts to challenge rivals and redefine global commerce.

A look inside the strategy behind Emanu-El Downtown's rapid growth and its new 11,000 sq ft Chelsea home, a blueprint for urban faith communities.

One year in, global broker ATFX expands in Phnom Penh, backed by regulators. The move signals a major shift for Cambodia's maturing financial markets.

Ricola bets big, moving beyond the medicine cabinet with new functional drops. Can the heritage brand reinvent itself for the modern wellness consumer?

A new digital marketplace lets dentists bid for your business, promising transparency and lower costs. But can this tech disruption solve the dental affordability crisis?

A missed clinical trial endpoint is often the end. For Elicio Therapeutics, a deeper data dive reveals a potential path forward for a high-need patient group.

Beyond a steady distribution, Chartwell's latest update signals a bold repositioning strategy. What does it mean for investors and the market?

Aurora Mobile integrates ShengShu's potent Vidu model, a strategic maneuver to challenge giants like OpenAI and Google by offering a unified, production-ready AI video platform.

The deal showcases a masterful exit in a tough market and signals deeper shifts in the pharma R&D landscape, where specialized research partners are king.

Trading Technologies partners with ICE to launch a new fixed income EMS, aiming to shatter market silos with a unified multi-asset trading experience.

New data reveals an oral drug can halt severe hereditary angioedema attacks in minutes, promising a future free from needles and fear for thousands.

Federal, provincial, and municipal leaders unite in Quebec City, signaling a new, systems-based approach to the housing crisis. Is this the model for a nation?